In this interview, Richard Becker, MD, gives us an insight into COVID-19 vasculitis and its manifestations.
Many studies suggest that there is an increased risk of dementia in patients with rheumatoid arthritis.
Mechanistic and outcomes studies are warranted to elucidate the lipid paradox and CVD risk in rheumatoid arthritis (RA).
In this Q&A, Maximilian Konig, MD, provides further insight into the overall effect of COVID-19 on patients with autoimmune diseases.
Although DAS28 metrics represent the gold standard in defining RA outcomes, they may not accurately capture a state of true remission.
Eric Dein, MD, discusses the pathophysiology, presentation, diagnostic approach, and symptom management of gastrointestinal dysmotility in systemic sclerosis.